According to our research, it has been discovered that the immune microenvironment of bladder cancer is significantly associated with YARS1, specifically the signalling pathways of the B cell receptor and T cell receptor (Figure 4A, B). This evidence concerns the gene YARS1 and urinary bladder carcinoma.